FLUVASTATIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluvastatin, and what generic alternatives are available?
Fluvastatin is a drug marketed by Mylan Pharms Inc, Teva Pharms, Beijing, Pharmobedient, and Teva Pharms Usa. and is included in five NDAs.
The generic ingredient in FLUVASTATIN is fluvastatin sodium. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fluvastatin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluvastatin
A generic version of FLUVASTATIN was approved as fluvastatin sodium by MYLAN PHARMS INC on April 11th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUVASTATIN?
- What are the global sales for FLUVASTATIN?
- What is Average Wholesale Price for FLUVASTATIN?
Summary for FLUVASTATIN
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for FLUVASTATIN |
| DailyMed Link: | FLUVASTATIN at DailyMed |


